Mortality reduction in severe community-acquired pneumonia : key findings from a large randomized controlled trial and their clinical implications
Errataetall: |
CommentOn: N Engl J Med. 2023 May 25;388(21):1931-1941. - PMID 36942789 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Annals of translational medicine - 11(2023), 11 vom: 25. Okt., Seite 395 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vornicu, Ovidiu [VerfasserIn] |
---|
Links: |
---|
Themen: |
28 days mortality |
---|
Anmerkungen: |
Date Revised 12.02.2024 published: Print-Electronic CommentOn: N Engl J Med. 2023 May 25;388(21):1931-1941. - PMID 36942789 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.21037/atm-23-1719 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364621796 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM364621796 | ||
003 | DE-627 | ||
005 | 20240213232616.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21037/atm-23-1719 |2 doi | |
028 | 5 | 2 | |a pubmed24n1290.xml |
035 | |a (DE-627)NLM364621796 | ||
035 | |a (NLM)37970598 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Vornicu, Ovidiu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mortality reduction in severe community-acquired pneumonia |b key findings from a large randomized controlled trial and their clinical implications |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 12.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentOn: N Engl J Med. 2023 May 25;388(21):1931-1941. - PMID 36942789 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
650 | 4 | |a Editorial | |
650 | 4 | |a Comment | |
650 | 4 | |a 28 days mortality | |
650 | 4 | |a Severe community-acquired pneumonia (severe CAP) | |
650 | 4 | |a hydrocortisone | |
650 | 4 | |a implications for clinicians | |
650 | 4 | |a septic shock excluded | |
700 | 1 | |a Perriens, Emily |e verfasserin |4 aut | |
700 | 1 | |a Blackman, Sydney |e verfasserin |4 aut | |
700 | 1 | |a Smoos, Elina |e verfasserin |4 aut | |
700 | 1 | |a Al Sammour, Christophe |e verfasserin |4 aut | |
700 | 1 | |a Oueslati, Ilann |e verfasserin |4 aut | |
700 | 1 | |a Philippot, Alexis |e verfasserin |4 aut | |
700 | 1 | |a Bankier, David Vidal |e verfasserin |4 aut | |
700 | 1 | |a Haddad, Charbel |e verfasserin |4 aut | |
700 | 1 | |a Bendoumou, Maha |e verfasserin |4 aut | |
700 | 1 | |a François, Tom |e verfasserin |4 aut | |
700 | 1 | |a Michaux, Isabelle |e verfasserin |4 aut | |
700 | 1 | |a Dincq, Anne-Sophie |e verfasserin |4 aut | |
700 | 1 | |a Evrard, Patrick |e verfasserin |4 aut | |
700 | 1 | |a Bulpa, Pierre |e verfasserin |4 aut | |
700 | 1 | |a Honore, Patrick M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of translational medicine |d 2013 |g 11(2023), 11 vom: 25. Okt., Seite 395 |w (DE-627)NLM23455374X |x 2305-5839 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2023 |g number:11 |g day:25 |g month:10 |g pages:395 |
856 | 4 | 0 | |u http://dx.doi.org/10.21037/atm-23-1719 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2023 |e 11 |b 25 |c 10 |h 395 |